Notice of intent to issue a Sole Source Award for tuberculosis clinical trial management services

Name: Notice of intent to issue a Sole Source Award for tuberculosis clinical trial management services
Creator: CENTERS FOR DISEASE CONTROL AND PREVENTION
Published: 2026-01-21T00:00:00+00:00
Keywords: CONTRACT

CENTERS FOR DISEASE CONTROL AND PREVENTIONHEALTH AND HUMAN SERVICES, DEPARTMENT OF.CENTERS FOR DISEASE CONTROL AND PREVENTION.CDC OFFICE OF ACQUISITION SERVICES

AI Overview

Sole source 1-year bridge contract with OpenClinica LLC for tuberculosis clinical trial management services, including FDA-compliant data intake, analysis, and patient enrollment tracking.

This summary is AI-generated from the official solicitation.

Key Details

Agency

CENTERS FOR DISEASE CONTROL AND PREVENTION

Funding Amount

—

Release Date

January 21, 2026

Due Date

February 5, 2026 (Closed)

Official Description

The Centers for Disease Control and Prevention Division of TB Elimination intends to award a sole source firm fixed price purchase order to OpenClinica LLC to provide a 1-year bridge contract for tuberculosis clinical trial management services to ensure the continuation of a 10-year cycle research portfolio that had lapsed due to the government wide shut down. OpenClinica LLC designed the current tracking system and has migrated all study data into their platform making it impractical to change...

View on official source